Literature DB >> 10683059

Genital herpes and public health: addressing a global problem.

L Corey1, H H Handsfield.   

Abstract

Genital herpes can be caused by herpes simplex virus 2 (HSV-2) or, less commonly, by herpes simplex virus 1 (HSV-1). With a seroprevalence of antibodies to HSV-2 of 22% in the general population, genital herpes is 1 of the 3 most prevalent sexually transmitted diseases (STDs) in the United States. A central issue in the public health problem of genital herpes is the high proportion of genital HSV infections that are unrecognized by both patients and clinicians. Persons who are HSV-2 seropositive may be symptomatic but nevertheless fail to recognize genital herpes; they serve as reservoirs for transmission. Physicians and patients must be aware of the subclinical presentation of genital herpes and the potential these patients have for transmitting HSV. Serious consequences of HSV infection include neonatal herpes and increased risk of human immunodeficiency virus transmission. Recommendations to physicians for prevention include using type-specific tests for HSV when screening for other STDs and testing for HSV when evaluating patients with genital ulcers. Researchers must evaluate the performance of type-specific tests and strategies to prevent transmission.

Entities:  

Mesh:

Year:  2000        PMID: 10683059     DOI: 10.1001/jama.283.6.791

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  53 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.

Authors:  Mark A Brockman; David M Knipe
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 3.  Recent advances: Sexually transmitted infections.

Authors:  R J Gilson; A Mindel
Journal:  BMJ       Date:  2001-05-12

4.  Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.

Authors:  Thomas L Cherpes; Rhoda L Ashley; Leslie A Meyn; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 5.  Ethics of screening for asymptomatic herpes virus type 2 infection.

Authors:  Ingela Krantz; Gun-Britt Löwhagen; Beth Maina Ahlberg; Tore Nilstun
Journal:  BMJ       Date:  2004-09-11

6.  Racial/ethnic disparities in undiagnosed infection with herpes simplex virus type 2.

Authors:  Enrique R Pouget; Trace S Kershaw; Kim M Blankenship; Jeannette R Ickovics; Linda M Niccolai
Journal:  Sex Transm Dis       Date:  2010-09       Impact factor: 2.830

7.  Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies.

Authors:  Sharmila M Reddy; P Balakrishnan; S Uma; S P Thyagarajan; Suniti Solomon
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

Review 8.  [Genital herpes].

Authors:  C J Adam; M Staehler; W Khoder; C Stief
Journal:  Urologe A       Date:  2006-12       Impact factor: 0.639

9.  Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.

Authors:  M J Binnicker; D J Jespersen; J A Harring
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

10.  The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic.

Authors:  J L Meyer; R A Crosby; W L H Whittington; D Carrell; R Ashley-Morrow; A S Meier; R D Harrington; R DiClemente; A Wald
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.